bomedemstat
imago biosciences
[]
today, we presented positive data from our ph 2 trials of #bomedemstat for treatment of essential thrombocythemia &amp; myelofibrosis at #eha2022. learn more about our progress tackling these serious #bloodcancers. et data mf data 
Translating Science into Transformative Medicines